drugset / Trial / NCT06400940
Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
Phase 4
Recruiting
640 enrolled
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
RandomizedParallel-groupOpen-labelTreatment
Summary
Prospective, post-registration, interventional, randomized, in parallel groups, multicenter Eurasian clinical study of DERIVO®/DERIVO® mini Aneurysm Embolization Device, Europe-Asia
Timeline
- Start
- 2023-08-17
- Primary completion
- 2026-08-17
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | — |
| Comparator | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Prasugrel | Small molecule | 10 mg | — |
| Subject | Ticagrelor | Small molecule | 180 mg | — |